Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare
Crinetics Pharmaceuticals Inc. Operating Income 2016–2025
Crinetics Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Crinetics Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -140.4 M, a 26.01% increase year-over-year.
- Crinetics Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -523.5 M, a 72.72% increase year-over-year.
- Crinetics Pharmaceuticals Inc. annual operating income for 2025 was -516.8 M, a 52.50% increase from 2024.
- Crinetics Pharmaceuticals Inc. annual operating income for 2024 was -338.9 M, a 52.22% increase from 2023.
- Crinetics Pharmaceuticals Inc. annual operating income for 2023 was -222.6 M, a 32.60% increase from 2022.
- Crinetics Pharmaceuticals Inc. annual operating income for 2022 was -167.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crinetics Pharmaceuticals Inc. Operating Income — FAQ
Crinetics Pharmaceuticals Inc. (CRNX) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Crinetics Pharmaceuticals Inc.'s operating income?
Crinetics Pharmaceuticals Inc. (CRNX) reported operating income of -$517M for fiscal 2025.
Where can I see CRNX's operating income history?
The chart and table above show Crinetics Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.